학술논문
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma
Document Type
Article
Author
Source
In: Annals of Hematology . (Annals of Hematology, February 2022, 101(2):335-340)
Subject
Language
English
ISSN
14320584
09395555
09395555